Publications

A Phase 1 Study of Donor Regulatory T-Cell Infusion plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs-Host Disease

AuthID
P-00X-SFZ

Author(s)

Whangbo, JS

Nikiforow, S

Kim, HT

Wahl, J

Reynolds, CG

Rai, SC

Kim, S

Burden, A

Alho, AC

Lacerda, JF

Alyea, EP

Cutler, CS

Ho, VT

Antin, JH

Soiffer, RJ

Ritz, J

Koreth, J

Document Type

Article

Year published

2022

Published

in BLOOD ADVANCES, ISSN: 2473-9529

Volume: 6, Issue: 21, Pages: 5786-5796 (11)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1182/bloodadvances.2021006625

Pubmed: 35475885

Wos: WOS:000897732500012

Source Identifiers

ISSN: 2473-9529

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

A Phase 1 Study of Donor Regulatory T-Cell Infusion plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs-Host Disease

Useful Links

Get Help

Federated Authentication (Click on the image)

A Phase 1 Study of Donor Regulatory T-Cell Infusion plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs-Host Disease

Useful Links

Get Help